# Curium to acquire Lantheus for up to $8.0 billion

Curium US Holdings LLC has entered into a definitive agreement to acquire Lantheus Holdings for $102.50 per share in cash at closing, plus up to $12.00 per share in contingent value rights, for a total transaction value of up to $8.0 billion.

- Type: Acquisition
- Announced: 2026-08-03
- Where: United States
- Value: $8.00B
- Status: announced
- Products: radiopharmaceuticals, radiodiagnostics, theranostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lantheus Holdings](https://endata.com/companies/23794.md) (target)
- [Curium](https://endata.com/companies/29511.md) (acquirer)

## Sources

- [investor.lantheus.com](https://investor.lantheus.com/news-releases/news-release-details/curium-announces-definitive-agreement-merge-lantheus), 2026-08-03: "Curium US will acquire all of the outstanding shares of Lantheus for $102.50 per share in cash at closing, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.